In this episode of our HSR mini-series, Norton Rose Fulbright lawyers Neely Agin, Luke McFarland and Mark Angland will be joined by Susan Feigin Harris, Co-Head of our Healthcare practice in the US, to discuss key highlights surrounding the FTC's final rule.
This rule will significantly change the reporting of mergers and acquisitions under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (also known as the HSR Act) and its nationwide rippling effects on the healthcare sector.
Continuing education information
For those attending the live webinar, this program is pending 0.75 Professional Practice CLE Credits in New York and 0.75 General CLE Credits in California, Illinois and Texas.